CNS Pharmaceuticals Statistics
Total Valuation
CNSP has a market cap or net worth of $2.00 million. The enterprise value is -$4.88 million.
Important Dates
The next estimated earnings date is Friday, May 15, 2026, before market open.
| Earnings Date | May 15, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CNSP has 811,449 shares outstanding. The number of shares has increased by 1,293.23% in one year.
| Current Share Class | 811,449 |
| Shares Outstanding | 811,449 |
| Shares Change (YoY) | +1,293.23% |
| Shares Change (QoQ) | +9.83% |
| Owned by Insiders (%) | 0.00% |
| Owned by Institutions (%) | 8.20% |
| Float | 715,826 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.34 |
| P/TBV Ratio | 0.44 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.98, with a Debt / Equity ratio of 0.07.
| Current Ratio | 1.98 |
| Quick Ratio | 1.76 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1,049.68 |
Financial Efficiency
Return on equity (ROE) is -296.30% and return on invested capital (ROIC) is -176.00%.
| Return on Equity (ROE) | -296.30% |
| Return on Assets (ROA) | -115.35% |
| Return on Invested Capital (ROIC) | -176.00% |
| Return on Capital Employed (ROCE) | -353.49% |
| Weighted Average Cost of Capital (WACC) | 6.48% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$3.17M |
| Employee Count | 5 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -77.10% in the last 52 weeks. The beta is 0.49, so CNSP's price volatility has been lower than the market average.
| Beta (5Y) | 0.49 |
| 52-Week Price Change | -77.10% |
| 50-Day Moving Average | 2.76 |
| 200-Day Moving Average | 6.20 |
| Relative Strength Index (RSI) | 45.97 |
| Average Volume (20 Days) | 39,784 |
Short Selling Information
The latest short interest is 54,014, so 6.66% of the outstanding shares have been sold short.
| Short Interest | 54,014 |
| Short Previous Month | 37,380 |
| Short % of Shares Out | 6.66% |
| Short % of Float | 7.55% |
| Short Ratio (days to cover) | 1.17 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -15.99M |
| Pretax Income | -15.85M |
| Net Income | -15.85M |
| EBITDA | -15.98M |
| EBIT | -15.99M |
| Earnings Per Share (EPS) | -$35.75 |
Full Income StatementBalance Sheet
The company has $7.20 million in cash and $328,571 in debt, with a net cash position of $6.87 million or $8.47 per share.
| Cash & Cash Equivalents | 7.20M |
| Total Debt | 328,571 |
| Net Cash | 6.87M |
| Net Cash Per Share | $8.47 |
| Equity (Book Value) | 4.52M |
| Book Value Per Share | 7.15 |
| Working Capital | 4.00M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$13.81 million and capital expenditures -$18,175, giving a free cash flow of -$13.83 million.
| Operating Cash Flow | -13.81M |
| Capital Expenditures | -18,175 |
| Depreciation & Amortization | 3,918 |
| Net Borrowing | -297,553 |
| Free Cash Flow | -13.83M |
| FCF Per Share | -$17.04 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CNSP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1,293.23% |
| Shareholder Yield | -1,293.23% |
| Earnings Yield | -794.05% |
| FCF Yield | -692.79% |
Analyst Forecast
The average price target for CNSP is $20.00, which is 709.72% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $20.00 |
| Price Target Difference | 709.72% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on July 22, 2025. It was a reverse split with a ratio of 1:12.
| Last Split Date | Jul 22, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:12 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |
